The Role of Capecitabine/Temozolomide (CAPTEM) in Metastatic Neuroendocrine Tumors: A Neuroendocrine Tumor Program Experience

被引：0
|
作者：
Ramirez, Robert A. [1 ,4 ]
Chauhan, Aman [2 ,4 ]
Beyer, David T. [3 ,4 ]
Boudreaux, J. Philip [3 ,4 ]
Wang, Yi-Zarn [3 ,4 ]
Woltering, Eugene A. [3 ,4 ]
机构：
[1] Ochsner Med Ctr, Dept Oncol, New Orleans, LA USA
[2] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA USA
[3] Louisiana State Univ, Hlth Sci Ctr, Dept Surg, New Orleans, LA USA
[4] Ochsner Kenner Neuroendocrine Clin, Kenner, LA USA
来源：
PANCREAS | 2016年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：480 / 480
页数：1
相关论文
共 50 条
  • [1] The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors
    Ramirez, Robert A.
    Beyer, David T.
    Chauhan, Aman
    Boudreaux, J. Philip
    Wang, Yi-Zarn
    Woltering, Eugene A.
    ONCOLOGIST, 2016, 21 (06): : 671 - 675
  • [2] Neoadjuvant Capecitabine/Temozolomide (CAPTEM) for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
    Squires, M. H.
    Rossfeld, K. K.
    Konda, B.
    Shah, M.
    Dillhoff, M.
    Abdel-Misih, S.
    Pawlik, T.
    Cloyd, J.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S138 - S139
  • [3] Capecitabine and temozolomide (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors
    Dogan, Izzet
    Tastekin, Didem
    Karabulut, Senem
    Sakar, Burak
    JOURNAL OF DIGESTIVE DISEASES, 2022, 23 (8-9) : 493 - 499
  • [4] Capecitabine and temozolomide (CAPTEM) in neuroendocrine tumor of unknown primary.
    Chauhan, Aman
    Raajasekar, Arun Kumar Arumugam
    Myint, Zin
    Murray, Leaundra
    Anthony, Lowell Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Capecitabine and temozolomide (CAPTEM) in patients with advanced neuroendocrine tumors: the experience of a Portuguese cancer center
    Chaves, A.
    Garcia, A.
    Ribeiro, J.
    Marques, M.
    Bonito, N.
    Jacinto, P.
    Gervasio, H.
    ANNALS OF ONCOLOGY, 2016, 27 : 53 - 53
  • [6] Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.
    Dogan, Izzet
    Tastekin, Didem
    Karabulut, Senem
    Sakar, Burak
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [7] Efficacy of Oral Chemotherapy with Capecitabine and Temozolomide (Captem) in Patients with Metastatic Neuroendocrine Tumors (NETS). A Single-Institution Experience
    Smiroldo, V
    Carnaghi, C.
    Lania, A.
    Bonifacio, C.
    Pepe, G.
    Zerbi, A.
    Rimassa, L.
    Lavezzi, E.
    Spaggiari, P.
    NEUROENDOCRINOLOGY, 2018, 106 : 206 - 206
  • [8] Efficacy of oral chemotherapy with capecitabine and temozolomide (CapTem) in metastatic neuroendocrine tumors (NETs): A single-institution experience.
    Smiroldo, Valeria
    Carnaghi, Carlo
    Rimassa, Lorenza
    Personeni, Nicola
    Pressiani, Tiziana
    Bozzarelli, Silvia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [9] Genomic correlates of response to capecitabine and temozolomide (CAPTEM) in pancreatic neuroendocrine tumors.
    Lee, Patrick
    Blais, Edik Matthew
    Gong, Jun
    Osipov, Arsen
    Moshayedi, Natalie
    Thomassian, Shant
    Ng, Camille
    Chuy, Jennifer W.
    Matrisian, Lynn McCormick
    Petricoin, Emanuel
    Pishvaian, Michael J.
    Hendifar, Andrew Eugene
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Capecitabine and temozolomide (CAPTEM) for intermediate to high grade metastatic neuroendocrine tumours (NET): A single centre experience
    Sahu, Arvind
    Jefford, Michael
    Lai-Kwon, Julia
    Hicks, Rod
    Thai, Alesha
    Michael, Michael
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 102 - 102
12345